Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyLactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cellsCancer as a metabolic diseaseThe histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolismPyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cellsErk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferationInduction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistanceThe glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferationLysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancerTargeting cellular metabolism to improve cancer therapeuticsUnderstanding the Warburg effect: the metabolic requirements of cell proliferationStable isotope-resolved metabolomics and applications for drug developmentGLO1 overexpression in human malignant melanomaHexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapyDichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerHeat shock factor 1 is a powerful multifaceted modifier of carcinogenesisHypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1Targeting Cancer Metabolism - Revisiting the Warburg EffectsFundamentals of cancer metabolismThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyTargeting metabolism in breast cancer: How far we can go?Integration of Mitochondrial Targeting for Molecular Cancer TherapeuticsA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisCancer Metabolism and Drug ResistanceMYC, Metabolism, and CancerEffect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in CancerDysregulated metabolism contributes to oncogenesisMetabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implicationSGF29 and Sry pathway in hepatocarcinogenesisSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsProgress toward overcoming hypoxia-induced resistance to solid tumor therapyComponents of cancer metabolism and therapeutic interventionsLactate dehydrogenase A in cancer: a promising target for diagnosis and therapyIs cancer a metabolic disease?Novel therapeutic targets of tumor metabolismP53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapyCancer cell metabolism: implications for therapeutic targetsTargeting glycogen metabolism in bladder cancerThe Warburg effect revisited--lesson from the Sertoli cellLipid metabolism in prostate cancer
P2860
Q21129303-E8BD4747-C0BA-4D5C-B2A0-906CA382DC78Q21133953-9569A283-33CF-4006-88BD-870E46DE35A6Q21245061-3B674BC7-B427-4348-849E-4A64D264760DQ24305332-2939613A-03A6-4F23-A8ED-E4F329432D0AQ24320179-40DDD89B-0817-419F-BD28-61A18BC73265Q24323390-6F061BF5-6C05-4FD0-A9DA-A2312D2E4701Q24329133-0AE66BC0-64D4-4D97-B23D-159637B094A6Q24336894-D896B1D0-CE88-4158-88B1-CDB8BC7A2AA2Q24337240-B32C4E49-2533-45C7-B2FF-1A224CE4F29CQ24596727-2877A619-9CFA-483A-BA7E-AA7D84C30A70Q24604760-E1DCE4EE-EDCB-4F9F-8B3F-9DAC625E198BQ24629149-BD250B3F-B5A5-4777-9735-44CC4AEA6877Q24630049-14C265CA-122B-4AA8-8946-BA9A72829336Q24646296-A71E63E5-E01C-4A06-976F-107C9F0B8BA3Q24652941-1FCDADBD-8025-41AD-BBD9-510217EA0C1EQ24655006-2F5E60BC-551D-4F99-A023-CD4C995E5495Q24681460-9094BC98-D90D-46F4-82EF-FCC06F08C77FQ26738876-1ACBE276-FB0A-43E0-8D7F-4DE1EE684F29Q26744062-A3D37079-CA2C-4EA5-A5B8-328104E5F891Q26766079-EDA53BFC-EB11-4D0F-B6FA-659388A324D0Q26767022-AFF64DF0-4A2D-41A8-A1B3-665E064FD585Q26771751-69E8EF5B-07A9-42E0-B97A-05A80EF7FFD8Q26774351-3C63353F-33D8-4EEC-BFD0-311EA7E9B5E6Q26782042-49385DBF-4D6F-469B-BE6F-C83DE62716D0Q26783555-B22D92CF-E662-463D-888E-431F38647C36Q26784557-9690F0E5-258E-49EF-AC36-427B70FD77E6Q26784630-A478F449-98E3-43CF-9120-4425AF79752FQ26795759-CCF82F63-15B4-4B50-9D8E-8B2F64BE8B0FQ26795760-08D385C8-E744-45D4-8B0E-3E0C4BFE0580Q26796203-5C7A5448-03CD-4AE2-91B3-45479B051F7EQ26796405-6581E88E-DED7-43BD-BE14-101D32DB19A2Q26823746-AD698385-B986-46C2-862D-46BA0D030448Q26851585-910552FF-C644-4ED5-998E-6BCB5AD3A88FQ26852241-64692161-B063-4761-9519-A8F56E209613Q27005930-FA5B2F0A-4155-4C71-B590-2FB31C1ED657Q27011547-8A6500EC-CAD9-476D-9006-EF46862AC005Q27013632-F175A4DF-333C-40A8-92B5-7BBDBA2C3F55Q27025144-EBF20CD1-47DE-46FF-8ED9-ACF49E304D63Q27025749-30094E24-13F3-4CE3-B674-C4A8A2602ADEQ27025766-83585DB4-B57A-4E5C-A5CB-93A1A2860871
P2860
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@ast
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@en
type
label
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@ast
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@en
prefLabel
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@ast
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@en
P2093
P3181
P1433
P1476
Attenuation of LDH-A expressio ...... siology, and tumor maintenance
@en
P2093
P304
P3181
P356
10.1016/J.CCR.2006.04.023
P407
P577
2006-06-01T00:00:00Z